arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Trulieve Cannabis Corp.

TRLV

$8.74 ▼ -0.24 (-2.67%) at close

7 Visible periods

26 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Weak

Bearish

auto_awesome

Analytical Summary

Trulieve Cannabis Corp. faces fundamental challenges with weakness in Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $1.7B

Dividend Yield —

Revenue Growth -0.4% ↘

Op. Margin 12.1% ↗

ROIC -133.8% ↘

FCF / Share $1.19 ↗

Trailing P/E —

Price / Book —

FCF Yield 13.7%

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

7-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$1.18B

— -0.4% —

Net Income Profit after all expenses

$-122.25M

↑ +23.9% —

Operating Margin Operating profit as % of sales

12.1%

↑ +47.4% 61th

FCF / Share Free cash flow per share

$1.19

↑ +52.5% —

Long-Term Debt Long-term obligations

$136.74M

↓ -62.5% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↓

Financial Health ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Revenue Growth YoY (%)	-0.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-109%)	5.1% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: At sector avg	-8.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-278%)	32.2% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+544%)	79.9% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1497%)	106.3% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2026%)	—
EPS Growth YoY (%)	26.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	65.4% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-115.1% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	N/M	-74.5% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	14.6% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	—
Net Income Growth YoY (%)	23.9% Good ↑ Good Improving Year-over-year change in net income	69.9% Excellent ↑ Excellent Improving Year-over-year change in net income	-111.0% Weak ↓ Weak Declining Year-over-year change in net income	N/M	-72.3% Weak Weak Year-over-year change in net income	18.7% Good Good Year-over-year change in net income	—
FCF Growth YoY (%)	52.5% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-8.3% Weak ↑ Weak Improving Year-over-year change in free cash flow	N/M	60.1% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-71821.6% Weak Weak Year-over-year change in free cash flow	99.5% Excellent Excellent Year-over-year change in free cash flow	—
Revenue CAGR 3Y (%)	-1.6% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	8.1% Fair ↓ Fair Declining Compound annual revenue growth over 3 years	29.4% Excellent Excellent Compound annual revenue growth over 3 years	69.9% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—
Revenue CAGR 5Y (%)	17.8% Excellent Excellent Compound annual revenue growth over 5 years	36.2% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Operating Margin (%) (%)	12.1% Fair ↑ Fair Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-19%)	8.2% Caution ↑ Caution Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-45%)	-19.6% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-231%)	2.6% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-83%)	21.3% Good ↓ Good Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+42%)	41.9% Excellent Excellent Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+179%)	44.8% Excellent Excellent Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+199%)
Effective Tax Rate (%) (%)	227.5% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	462.6% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-53.2% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-373.3% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	88.3% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	60.0% Weak Weak Actual taxes paid relative to pre-tax income Optimal: 15-25%	48.8% Weak Weak Actual taxes paid relative to pre-tax income Optimal: 15-25%
Profit Margin (%) (%)	-10.3% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-203%)	-13.5% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-235%)	-47.2% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-572%)	-20.4% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-304%)	1.9% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-81%)	12.1% Fair Fair Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+21%)	21.0% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+110%)
FCF Margin (%) (%)	19.4% Good ↑ Good Improving Free cash flow as a percentage of revenue Optimal: > 10%	12.5% Fair ↑ Fair Improving Free cash flow as a percentage of revenue Optimal: > 10%	14.3% Fair ↑ Fair Improving Free cash flow as a percentage of revenue Optimal: > 10%	-11.4% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-28.0% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-0.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-20.9% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%
FCF / Net Income (x)	-1.87x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.93x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-0.30x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.56x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-15.08x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.00x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	-0.99x Weak Weak Free cash flow relative to reported net income Optimal: > 1x

🎯 Is capital allocation efficient? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	-133.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-97.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-93.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	28.3% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	5.0% Caution Caution Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	5.3% Caution ↑ Caution Improving Operating profit relative to total assets Optimal: > 10%	3.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-8.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	1.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	5.8% Caution Caution Operating profit relative to total assets Optimal: > 10%	27.0% Excellent Excellent Operating profit relative to total assets Optimal: > 10%	—

⚖️ Is the balance sheet risky? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Interest Coverage (x)	2.04x Caution ↑ Caution Improving Operating income divided by interest expense Optimal: > 5x	1.49x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-2.72x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	0.41x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	5.74x Good ↓ Good Declining Operating income divided by interest expense Optimal: > 5x	10.79x Excellent Excellent Operating income divided by interest expense Optimal: > 5x	12.52x Excellent Excellent Operating income divided by interest expense Optimal: > 5x
Net Debt (USD)	$-118.79M	$126.03M	$161.84M	$329.40M	$232.84M	$-146.71M	—
Debt / EBITDA (x)	0.95x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	3.73x Caution ↑ Caution Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.64x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	4.98x Weak Weak Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	1.98x Good Good Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—

📊 What does each share earn? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Revenue per Share (USD)	$6.17	$6.24	$5.98	$6.59	$6.73	$4.59	$2.29
Basic EPS, GAAP (USD)	$-0.58	$-0.79	$-2.28	$-1.06	$0.14	$0.55	$0.48
Free Cash Flow per Share (USD)	$1.19	$0.78	$0.85	$-0.75	$-1.89	$-0.00	$-0.48
Basic Weighted Avg Shares (shares)	191.32M	189.99M	188.97M	188.00M	139.37M	113.57M	110.21M

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$435.77M	$466.06M	$362.50M	$383.25M	$355.48M	$185.33M	—
LT Debt (USD)	$136.74M	$364.84M	$363.21M	$541.66M	$462.93M	—	—

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Sales/Revenue/Turnover (USD)	$1.18B	$1.19B	$1.13B	$1.24B	$937.98M	$521.53M	$252.82M
Depreciation Expense (USD)	—	—	—	$76.40M	$34.80M	$21.10M	$9.30M
Net Income, GAAP (USD)	$-122.25M	$-160.58M	$-533.14M	$-252.73M	$17.45M	$63.00M	$53.09M
Operating Cash Flow (USD)	$272.82M	$271.48M	$201.84M	$23.10M	$12.90M	$99.64M	$19.07M

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 26 quarters

Trulieve Cannabis Corp.

Analytical Summary

7-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare TRLV with peers